All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials
Nutrition, Metabolism & Cardiovascular Diseases | Nov 04, 2021
Most read this week